The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
Open accessAbstract
The level of copy number alteration (CNA), termed CNA burden, in the tumor genome is associated with recurrence of primary prostate cancer. Whether CNA burden is associated with prostate cancer survival or outcomes in other cancers is unknown. We analyzed the CNA landscape of conservatively treated prostate cancer in a biopsy and transurethral resection cohort, reflecting an increasingly common treatment approach. We find that CNA burden is prognostic for cancer-specific death, independent of standard clinical prognosticators. More broadly, we find CNA burden is significantly associated with disease-free and overall survival in primary breast, endometrial, renal clear cell, thyroid, and colorectal cancer in TCGA cohorts. To assess clinical applicability, we validated these findings in an independent pan-cancer cohort of patients whose tumors were sequenced using a clinically-certified next generation sequencing assay (MSK-IMPACT), where prognostic value varied based on cancer type. This prognostic association was affected by incorporating tumor purity in some cohorts. Overall, CNA burden of primary and metastatic tumors is a prognostic factor, potentially modulated by sample purity and measurable by current clinical sequencing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Self-citationComprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380
Self-citationThe Molecular Taxonomy of Primary Prostate Cancer
Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S., Andry, C. D., Annala, M., Aprikian, A., Armenia, J., Arora, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.025 · Cited by 3,110
Self-citationIntegrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Self-citationTracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Goodman, A. M., Kato, S., Bazhenova, L., Patel, S. P., Frampton, G. M., Miller, V., Stephens, P. J., Daniels, G. A., & Kurzrock, R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0386 · Cited by 2,264
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
Cheng, D. T., Mitchell, T. N., Zehir, A., Shah, R. H., Benayed, R., Syed, A., Chandramohan, R., Liu, Z. Y., Won, H. H., Scott, S. N., et al. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.12.006 · Cited by 2,119
Absolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C.-Z., Wala, J., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,870
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., Zhang, H., McLellan, M., Yau, C., Kandoth, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.033 · Cited by 1,858
Self-citationShen, R., & Seshan, V. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw520 · Cited by 1,258
COOPERBERG, M. R., PASTA, D. J., ELKIN, E. P., LITWIN, M. S., LATINI, D. M., Du CHANE, J., & CARROLL, P. R. (2005) · Journal of Urology · doi:10.1097/01.ju.0000158155.33890.e7 · Cited by 772
Abida, W., Armenia, J., Gopalan, A., Brennan, R., Walsh, M., Barron, D., Danila, D., Rathkopf, D., Morris, M., Slovin, S., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00029 · Cited by 541
Self-citationImplementing Genome-Driven Oncology
Hyman, D. M., Taylor, B. S., & Baselga, J. (2017) · Cell · doi:10.1016/j.cell.2016.12.015 · Cited by 503
Self-citationGenetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi, T., Kallioniemi, A. H., Syvänen, A. C., HYYTINEN, E.-R., Karhu, R., Tammela, T. L. J., Isola, J. J., & Kallioniemi, O. (1995) · PubMed · Cited by 480
Copy number signatures and mutational processes in ovarian carcinoma
Macintyre, G., Goranova, T. E., De Silva, D., Ennis, D., Piskorz, A. M., Eldridge, M., Sie, D., Lewsley, L.-A., Hanif, A., Wilson, C., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0179-8 · Cited by 449
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
Walther, A., Houlston, R., & Tomlinson, I. (2008) · Gut · doi:10.1136/gut.2007.135004 · Cited by 368
Viswanathan, S. R., Ha, G., Hoff, A. M., Wala, J. A., Carrot-Zhang, J., Whelan, C. W., Haradhvala, N. J., Freeman, S. S., Reed, S. C., Rhoades, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.036 · Cited by 365 · cited 1×
“CNV patterns or clusters have been associated with high Gleason prostate cancer (Gleason 8 + compared to Gleason 6–7 [Williams et al., 2014]) and recurrent disease (compared to primary [Visakorpi et al., 1995; Cancer Genome Atlas Research Network, 2015; Viswanathan et al., 2018]).”
BackgroundCopy number alteration burden predicts prostate cancer relapse
Hieronymus, H., Schultz, N., Gopalan, A., Carver, B. S., Chang, M. T., Xiao, Y., Heguy, A., Huberman, K., Bernstein, M., Assel, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411446111 · Cited by 364
Self-citationDeletions linked to TP53 loss drive cancer through p53-independent mechanisms
Liu, Y., Chen, C., Xu, Z., Scuoppo, C., Rillahan, C. D., Gao, J., Spitzer, B., Bosbach, B., Kastenhuber, E. R., Baslan, T., et al. (2016) · Nature · doi:10.1038/nature17157 · Cited by 279
Self-citationRevisiting tumour aneuploidy — the place of ploidy assessment in the molecular era
Danielsen, H. E., Pradhan, M., & Novelli, M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.208 · Cited by 162
Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy
Liang, L., Fang, J.-Y., & Xu, J. (2015) · Oncogene · doi:10.1038/onc.2015.209 · Cited by 158
Long-term outcome among men with conservatively treated localised prostate cancer
on behalf of the Transatlantic Prostate Group, Cuzick, J. M., Fisher, G., Kattan, M. W., Berney, D. M., Oliver, R. T. D., Foster, C. S., Møller, H., Reuter, V., Fearn, P., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603411 · Cited by 134
Self-citationUnraveling the clonal hierarchy of somatic genomic aberrations
Prandi, D., Baca, S. C., Romanel, A., Barbieri, C. E., Mosquera, J., Fontugne, J., Beltran, H., Sboner, A., Garraway, L. A., Rubin, M. A., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0439-6 · Cited by 104
Williams, J. L., Greer, P. A., & Squire, J. A. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.09.003 · Cited by 100
Wang, H., Liang, L., Fang, J.-Y., & Xu, J. (2015) · Oncogene · doi:10.1038/onc.2015.304 · Cited by 93
Non‐invasive detection of genome‐wide somatic copy number alterations by liquid biopsies
Heitzer, E., Ulz, P., Geigl, J. B., & Speicher, M. R. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.004 · Cited by 77
Xia, S., Kohli, M., Du, M., Dittmar, R. L., Lee, A., Nandy, D. K., Yuan, T., Guo, Y., Wang, Y., Tschannen, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3845 · Cited by 51
The Role of Circulating Tumor DNA in Renal Cell Carcinoma
Bergerot, P. G., Hahn, A. W., Bergerot, C. D., Jones, J. O., & Pal, S. K. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0530-4 · Cited by 49
Castro, E., Jugurnauth-Little, S., Karlsson, Q., Al‐Shahrour, F., Piñeiro-Yáñez, E., de Poll, F. V., Leongamornlert, D. A., Dadaev, T., Govindasami, K., Guy, M., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv356 · Cited by 44
Camacho, N., Loo, P. V., Edwards, S. E., Kay, J. D., Matthews, L. H., Haase, K., Clark, J., Dennis, N. M., Thomas, S. A., Kremeyer, B., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007001 · Cited by 44
Self-citationCopy-number analysis identified new prognostic marker in acute myeloid leukemia
Nibourel, O., Guihard, S., Roumier, C., Pottier, N., Terré, C., Paquet, A. C., Peyrouze, P., Geffroy, S., Quentin, S., Alberdi, A., et al. (2016) · Leukemia · doi:10.1038/leu.2016.265 · Cited by 41
Selective and mechanistic sources of recurrent rearrangements across the cancer genomePreprint
Wala, J. A., Shapira, O., Li, Y., Craft, D., Schumacher, S. E., Imielinski, M. B., Haber, J. E., Roberts, N. D., Yao, X., Stewart, C., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/187609 · Cited by 32
Vujković, M., Attiyeh, E. F., Ries, R. E., Goodman, E. K., Ding, Y., Kavčič, M., Alonzo, T. A., Wang, Y.-C., Gerbing, R. B., Sung, L., et al. (2017) · Blood · doi:10.1182/blood-2017-03-772384 · Cited by 29
Integration and comparison of different genomic data for outcome prediction in cancer
Gómez-Rueda, H., Martínez-Ledesma, E., Martínez‐Torteya, A., Palacios‐Corona, R., & Treviño, V. (2015) · BioData Mining · doi:10.1186/s13040-015-0065-1 · Cited by 24
Coordinated Tumor Suppression by Chromosome 8p
Tschaharganeh, D. F., Bosbach, B., & Lowe, S. W. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.011 · Cited by 17
Robust genomic copy number predictor of pan cancer metastasis
Pearlman, A. W., Upadhyay, K., Cole, K., Loke, J., Sun, K., Fineberg, S., Freedland, S. J., Shao, Y., & D, H. O. M. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.165 · Cited by 11
Cited by
Context is everything: aneuploidy in cancer
Ben-David, U., & Amon, A. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0171-x · Cited by 665
Nguyen, B., Fong, C., Luthra, A., Smith, S. A., DiNatale, R. G., Nandakumar, S., Walch, H., Chatila, W. K., Madupuri, R., Kundra, R., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.003 · Cited by 623
Self-citationPervasive chromosomal instability and karyotype order in tumour evolution
Watkins, T. B. K., Lim, E. L., Petkovic, M., Elizalde, S., Birkbak, N. J., Wilson, G. A., Moore, D. A., Grönroos, E., Rowan, A., Dewhurst, S. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2698-6 · Cited by 370
Liu, L., Bai, X., Wang, J., Tang, X.-R., Wu, D.-H., Du, S.-S., Du, X.-J., Zhang, Y.-W., Zhu, H.-B., Fang, Y., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0558 · Cited by 322
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Cohen-Sharir, Y., McFarland, J. M., Abdusamad, M., Marquis, C., Bernhard, S. V., Kazachkova, M., Tang, H., Ippolito, M. R., Laue, K., Zerbib, J., et al. (2021) · Nature · doi:10.1038/s41586-020-03114-6 · Cited by 290
Metadata
- Authors
- Hieronymus, H., Murali, R., Tin, A., Yadav, K., Abida, W., Moller, H., Berney, D., Scher, H., Carver, B., Scardino, P., Schultz, N., Taylor, B., Vickers, A., Cuzick, J., & Sawyers, C. L.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2018-09-04
- Volume
- 7
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2889721546
- Cited by
- 282
- References
- 41
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.